Clinical Trial Update: Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of cotrimoxazole use in immunocompetent HIV patients on carriage of antimicrobial-resistant bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumocystis Pneumonia

Drugs mentioned

• Cotrimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University of Bergen | Conditions: HIV-1-infection, Pneumocystis Pneumonia | Phase 4 | Status: COMPLETED